Equity Research

Myles Minter Quoted in MedCity News

William Blair research analyst Myles Minter’s note on the swift FDA approval of Alzheimer’s drug Leqembi was cited in MedCity News.

Our Latest News

Thursday, November 21, 2024

Process Sensing Technologies Has Been Acquired by DwyerOmega

William Blair acted as financial advisor to Process Sensing Technologies, a portfolio company of AEA Investors, in connection with its sale to DwyerOmega, a portfolio company of Arcline Investment Management.
Read more
Tuesday, November 19, 2024

Reducing Real-World Emissions

Shivani Patel, a sustainability analyst on our U.S. growth and core equity team, discusses what she learned at a sustainability conference about the push to reduce real-world emissions.
Watch the video
Tuesday, November 19, 2024

Risk: Understanding and Managing an Inevitable Part of Investing

Identifying the various types of risk that investors face can help you think strategically about how to manage risk in a way that aligns with your goals and objectives.
Read more

See more news

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures